Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 335 | 72.3% |
| Travel and Lodging | $196,711 | 563 | 13.7% |
| Honoraria | $95,414 | 36 | 6.6% |
| Consulting Fee | $69,409 | 30 | 4.8% |
| Food and Beverage | $33,997 | 473 | 2.4% |
| Education | $2,820 | 72 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $494,518 | 366 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $419,068 | 607 | $0 (2024) |
| Genentech USA, Inc. | $117,063 | 100 | $0 (2021) |
| GENZYME CORPORATION | $93,371 | 58 | $0 (2023) |
| Lilly USA, LLC | $78,864 | 137 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $69,895 | 39 | $0 (2023) |
| CSL Behring | $57,130 | 56 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $50,213 | 49 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $35,188 | 49 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $12,071 | 18 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,369 | 16 | Alexion Pharmaceuticals, Inc. ($14,674) |
| 2023 | $24,884 | 16 | Alexion Pharmaceuticals, Inc. ($19,037) |
| 2022 | $134,222 | 139 | Alexion Pharmaceuticals, Inc. ($65,604) |
| 2021 | $84,029 | 70 | Alexion Pharmaceuticals, Inc. ($42,907) |
| 2020 | $45,978 | 59 | Alexion Pharmaceuticals, Inc. ($30,244) |
| 2019 | $443,005 | 414 | E.R. Squibb & Sons, L.L.C. ($145,087) |
| 2018 | $346,273 | 386 | E.R. Squibb & Sons, L.L.C. ($169,585) |
| 2017 | $344,111 | 409 | E.R. Squibb & Sons, L.L.C. ($179,845) |
All Payment Transactions
1,509 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,590.00 | General |
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $125.62 | General |
| Category: Rare Disease | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $104.59 | General |
| 06/24/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Education | In-kind items and services | $93.95 | General |
| Category: Rare Disease | ||||||
| 03/02/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $667.20 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $371.77 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $176.37 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $74.73 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $54.80 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $31.32 | General |
| 03/01/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,870.00 | General |
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $98.30 | General |
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $43.80 | General |
| 02/29/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $8.20 | General |
| 10/05/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,920.00 | General |
| 10/03/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.93 | General |
| 10/03/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $27.12 | General |
| 09/15/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/15/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.57 | General |
| 09/14/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $317.96 | General |
| 09/14/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $299.15 | General |
| 09/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $147.53 | General |
| 06/27/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $123.33 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 228 | 438 | $111,035 | $47,403 |
| 2022 | 4 | 256 | 458 | $121,123 | $51,858 |
| 2021 | 4 | 290 | 552 | $138,891 | $60,529 |
| 2020 | 5 | 331 | 713 | $176,850 | $73,470 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 199 | $47,622 | $21,358 | 44.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 145 | $31,154 | $13,975 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 45 | $18,174 | $6,258 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $11,275 | $4,843 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 16 | $2,810 | $969.06 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 155 | $35,084 | $17,408 | 49.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 102 | $40,596 | $16,125 | 39.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 162 | $34,344 | $13,221 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $7,488 | $3,345 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 16 | $3,611 | $1,759 | 48.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 112 | 120 | $47,760 | $18,862 | 39.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 79 | 219 | $46,428 | $18,203 | 39.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 125 | $27,075 | $14,829 | 54.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 32 | 67 | $14,415 | $7,343 | 50.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 21 | $3,213 | $1,291 | 40.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 106 | 314 | $67,510 | $28,420 | 42.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 244 | $51,728 | $20,882 | 40.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 111 | 121 | $48,158 | $20,142 | 41.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 20 | 20 | $6,500 | $2,793 | 43.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 12 | 14 | $2,954 | $1,234 | 41.8% |
About Dr. Damian Laber, MD
Dr. Damian Laber, MD is a Hematology & Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922089747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damian Laber, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $17,369 received in 2024. These payments were reported across 1,509 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Laber has provided services to 1,105 Medicare beneficiaries, totaling 2,161 services with total Medicare billing of $233,259. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Tampa, FL
- Active Since 11/09/2005
- Last Updated 11/03/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922089747
Products in Payments
- OPDIVO (Biological) $322,963
- EMPLICITI (Biological) $171,555
- SOLIRIS (Drug) $146,014
- GAZYVA (Biological) $77,261
- LIBTAYO (Drug) $71,822
- CYRAMZA (Drug) $65,451
- ONIVYDE (Drug) $59,798
- LIBTAYO (Biological) $44,564
- Ultomiris (Drug) $40,049
- ULTOMIRIS (Biological) $35,071
- Empaveli (Drug) $33,418
- ULTOMIRIS (Drug) $28,560
- Multiple Products (Biological) $21,030
- Idelvion (Biological) $19,188
- Afstyla (Biological) $16,787
- JEVTANA (Drug) $15,733
- TECENTRIQ (Biological) $13,136
- BEVYXXA (Drug) $12,071
- Rituxan (Biological) $9,689
- SOMATULINE DEPOT (Drug) $7,395
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tampa
Eduardo Sotomayor, Md, MD
Hematology & Oncology — Payments: $447,992
Ariel Grajales-Cruz
Hematology & Oncology — Payments: $424,303
Dr. Kendra Sweet, M.d, M.D
Hematology & Oncology — Payments: $215,309
Khaldoun Almhanna, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $173,538
Hayder Saeed, M.d, M.D
Hematology & Oncology — Payments: $140,365
Dr. Hatem Soliman, Md, MD
Hematology & Oncology — Payments: $138,958